Your Health, We Care
Release date: 2024-07-09 15:44:48 Recommended: 145
Adaglacib is a specific oral inhibitor targeting the KRAS G12C mutant, suitable for adult patients with specific lung diseases who have been approved by FDA for testing, confirmed to have KRAS G12C mutations, and have received at least one systemic treatment. Adaglacib inhibits the activity of KRAS G12C mutant proteins, thereby preventing malignant cell proliferation and metastasis.
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended：354Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended：363Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended：423Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended：284Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended：477Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended：295Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended：462Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended：367Release date: 2024-07-09
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the r···【more】
Recommended：67Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved nirap···【more】
Recommended：60Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved···【more】
Recommended：79Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisoca···【more】
Recommended：74Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full ap···【more】
Recommended：94Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phas···【more】
Recommended：90Release date: 2025-12-01
